Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ARS Pharmaceuticals Says $314M In Cash, Cash Equivalents, And Short-term Investments At Year-end 2024, Supporting An Increased Investment In Commercialization In 2025 While Maintaining An Operating Runway Of At Least Three Years

Author: Benzinga Newsdesk | March 20, 2025 07:04am

Posted In: SPRY